Hello, is there any question related to the equity of your subsidiary that has been submitted by the equity Department of the company? Whether to file a lawsuit through legal channels?
Shanghai Kehua Bio-Engineering Co.Ltd(002022) (002022. SZ) said on the investor interaction platform on February 13 that the relevant disputes between the company and the minority shareholders of Tianlong company have been in the process of arbitration proceedings. Since July 14, 2021, the company has continuously fulfilled the obligation of information disclosure on this matter. Please check the relevant announcements.
